|
COPYRIGHT 2002 Fort Worth Star-Telegram
Byline: Trebor Banstetter
Aug. 1--FORT WORTH, Texas--Fueled by strong sales of its new glaucoma drug, eye-care giant Alcon saw its profit leap 58 percent during the second quarter.
The earnings report was the second to be posted by the company, which had its initial public offering in March. Alcon executives said sales grew 9 percent to $809 million during the quarter, compared with $746 million last year.
Profit jumped...
Read the full article for free courtesy of your local library.
| 
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
